Caption Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,457
Closed -$141K 1623
2025
Q4
$108K Buy
+5,457
New +$105K ﹤0.01% 1436
2025
Q2
Sell
-98,128
Closed -$1.25M 1499
2025
Q1
$1.24M Sell
98,128
-54,466
-36% -$855K 0.01% 842
2024
Q4
$3.36M Buy
152,594
+119,694
+364% +$2.52M 0.03% 514
2024
Q3
$586K Sell
32,900
-90,989
-73% -$1.46M 0.01% 903
2024
Q2
$1.99M Buy
+123,889
New +$1.96M 0.03% 479
2023
Q2
Sell
-61,042
Closed -$1.06M 1143
2023
Q1
$1.06M Buy
61,042
+906
+2% +$16.1K 0.02% 617
2022
Q4
$1.02M Buy
+60,136
New +$970K 0.02% 748
2021
Q4
Sell
-769,900
Closed -$9.69M 1642
2021
Q3
$6.09M Buy
769,900
+58,006
+8% +$399K 0.07% 370
2021
Q2
$4.89M Buy
711,894
+342,905
+93% +$2.11M 0.06% 372
2021
Q1
$2.25M Buy
+368,989
New +$1.54M 0.05% 484

Other funds holding CLMT

Caption Management's CLMT Position: Q1 2026 in Review

Caption Management sold out of Calumet Specialty Products (CLMT) in Q1 2026, closing a stake of 5,457 shares — an estimated $141K sold.

Caption Management first reported a position in CLMT in Q1 2021 and held it in 10 quarters. The position peaked at $6.09M in Q3 2021. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Caption Management reported no remaining Calumet Specialty Products position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 5,457 Calumet Specialty Products shares in Q1 2026, an estimated $141K.
  • Caption Management first reported a position in Calumet Specialty Products in Q1 2021 and held it in 10 quarters.
  • Caption Management's Calumet Specialty Products position peaked at $6.09M in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.